Weight loss in nonalcoholic fatty liver disease patients in an ambulatory care setting is largely unsuccessful but correlates with frequency of clinic visits

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Dudekula, Anwar ^a   Rachakonda, Vikrant ^a   Shaik, Beebijan ^a   Behari, Jaideep ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AMBULATORY CARE; ARTICLE; BODY MASS; BODY WEIGHT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREDICTION; PREVALENCE; PROFESSIONAL PRACTICE; RETROSPECTIVE STUDY; UNDERWEIGHT; WEIGHT REDUCTION; COMPLICATION; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; STATISTICAL MODEL;

ADULT; AMBULATORY CARE; BODY MASS INDEX; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; OVERWEIGHT; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84910626241     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0111808     Document Type: Article

References (31)

1. Targher G, Day CP, Bonora E (2010) Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 363: 1341-1350.
2. Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and nonalcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34: 274-285.
3. Williams CD, Stengel J, Asike M.I., Torres DM, Shaw J, et al. (2011) Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology 140: 124-131.
4. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P., Horton JD, et al. (2004) Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 40: 1387-1395.
5. Amarapurkar DN, Hashimoto E, Lesmana L.A., Sollano JD, Chen PJ, et al. (2007) How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences? J Gastroenterol Hepatol 22: 788-793.
6. Church TS, Kuk JL, Ross R, Priest E.L., Biltoft E., et al. (2006) Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease. Gastroenterology 130: 2023-2030.
7. Lazo M, Solga SF, Horska A, Bonekamp S., Diehl AM, et al. (2010) Effect of a 12-month intensive lifestyle intervention on hepatic steatosis in adults with type 2 diabetes. Diabetes Care 33: 2156-2163.
8. Harrison SA, Fecht W, Brunt E.M., Neuschwander-Tetri BA (2009) Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial. Hepatology 49: 80-86.
9. Zelber-Sagi S, Kessler A, Brazowsky E., Webb M, Lurie Y, et al. (2006) A double-blind randomized placebo-controlled trial of orlistat for the treatment of nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol 4: 639-644.
10. Promrat K, Kleiner DE, Niemeier H.M., Jackvony E., Kearns M, et al. (2010) Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis. Hepatology 51: 121-129.
11. Kugelmas M, Hill DB, Vivian B, Marsano L., McClain CJ (2003) Cytokines and NASH: a pilot study of the effects of lifestyle modification and vitamin E. Hepatology 38: 413-419.
12. Chalasani N, Younossi Z, Lavine J.E., Diehl AM, Brunt EM, et al. (2012) The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology 55: 2005-2023.
13. Penn L, White M, Lindstrom J., den Boer AT, Blaak E, et al. (2013) Importance of weight loss maintenance and risk prediction in the prevention of type 2 diabetes: analysis of European Diabetes Prevention Study RCT. PLoS One 8: e57143.
14. Cruz RJ Jr, Dew MA, Myaskovsky L, Goodpaster B., Fox K, et al. (2013) Objective radiologic assessment of body composition in patients with end-stage liver disease: going beyond the BMI. Transplantation 95: 617-622.
15. McHugh PP, Shah SH, Johnston T.D., Gedaly R., Ranjan D (2010) Predicting dry weight in patients with ascites and liver cirrhosis using computed tomography imaging. Hepatogastroenterology 57: 591-597.
16. Nehra MS, Ma Y, Clark C., Amarasingham R, Rockey DC, et al. (2013) Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 47: e50-54.
17. (2000) Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 894: i-xii, 1-253.
18. Moyer VA, Force USPST (2012) Screening for and management of obesity in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 373-378.
19. Moyer VA, Force USPST (2012) Behavioral counseling interventions to promote a healthful diet and physical activity for cardiovascular disease prevention in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 157: 367-371.
20. Long JS, Freese J (2005) Regression Models for Categorical Outcomes using Stata: Second Edition. College Station, TX: Stata Press.
21. Bellentani S, Tiribelli C, Saccoccio G., Sodde M, Fratti N, et al. (1994) Prevalence of chronic liver disease in the general population of northern Italy: the Dionysos Study. Hepatology 20: 1442-1449.
22. Bellentani S, Bedogni G, Miglioli L., Tiribelli C (2004) The epidemiology of fatty liver. Eur J Gastroenterol Hepatol 16: 1087-1093.
23. Leibel RL, Rosenbaum M, Hirsch J (1995) Changes in energy expenditure resulting from altered body weight. N Engl J Med 332: 621-628.
24. Rosenbaum M, Hirsch J, Gallagher D.A., Leibel RL (2008) Long-term persistence of adaptive thermogenesis in subjects who have maintained a reduced body weight. Am J Clin Nutr 88: 906-912.
25. Wadden TA, Berkowitz RI, Womble L.G., Sarwer DB, Phelan S, et al. (2005) Randomized trial of lifestyle modification and pharmacotherapy for obesity. N Engl J Med 353: 2111-2120.
26. Tsai AG, Wadden TA, Womble L.G., Byrne KJ (2005) Commercial and self-help programs for weight control. Psychiatr Clin North Am 28: 171-192, ix.
27. Wing RR, Tate DF, Gorin A.A., Raynor HA, Fava JL (2006) A self-regulation program for maintenance of weight loss. N Engl J Med 355: 1563-1571.
28. Svetkey LP, Stevens VJ, Brantley P.J., Appel LJ, Hollis JF, et al. (2008) Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 299: 1139-1148.
29. Haufe S, Haas V, Utz W., Birkenfeld AL, Jeran S, et al. (2013) Long-lasting improvements in liver fat and metabolism despite body weight regain after dietary weight loss. Diabetes Care 36: 3786-3792.
30. Perseghin G, Lattuada G, De Cobelli F, Ragogna F, Ntali G., et al. (2007) Habitual physical activity is associated with intrahepatic fat content in humans. Diabetes Care 30: 683-688.
31. Johnson NA, Sachinwalla T, Walton D.W., Smith K., Armstrong A, et al. (2009) Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. Hepatology 50: 1105-1112.